NEWS

Fitbit and Jawbone back in court September 1

Fitness device company Fitbit and rival Jawbone will be back in court on Thursday, September 1, when a claim construction hearing will take place in a lawsuit by Fitbit against Jawbone filed in San Jose federal court, Reuters reported. Fitbit is…


Fitbit cleared of stealing Jawbone trade secrets

Fitbit said the International Trade Commission (ITC) issued an initial determination in favor of Fitbit following an ITC investigation brought by rival firm Jawbone. Fitbit said the administrative law judge who presided over the merits hearing concluded “that Fitbit did not misappropriate any Jawbone trade secrets.”…


FORMA hires Shair as new chief IP counsel

FORMA Therapeutics, a clinical-stage and research and development company, announced the appointment of Karoline Shair as vice president, legal and chief intellectual property counsel. Shair joins FORMA with more than 20 years of experience in the biotechnology and pharmaceutical sector. She most…


Apple teases with September 7 invitation

Apple has invited journalists to an event in San Francisco on September 7 where it is expected to unveil a number of product upgrades. Bloomberg has reported that Apple is expected to introduce next-generation versions of the iPhone and Apple…


Mylan launches half-price generic EpiPen

Mylan said its US subsidiary will launch the first generic of its is allergy EpiPen Auto-Injector at a price of $300 for a two-pack carton — about half the price of the branded product, which is still patent protected. Mylan said the authorized generic will be identical to…


Gillette sues Edgewell for patent infringement

The Gillette Company, owned Procter & Gamble, filed a lawsuit in the US District Court in the Southern District of New York against Edgewell Personal Care, a manufacturer of shaving products. The lawsuit focuses on Edgewell’s three-bladed private label razors with…


Drug patent ruling lifts Vanda Pharmaceuticals

Vanda Pharmaceuticals said a US District Court in Delaware ruled that Roxane Laboratories infringed two of its patents by submitting to the FDA an abbreviated new drug application (ANDA) seeking permission to market a generic version of schizophrenia drug Fanapt before the expiration of Vanda’s patents. Vanda’s…


P&G prevails against private label firms

Procter & Gamble said a federal court issued a permanent injunction banning a private label manufacturer from infringing P&G’s Crest Whitestrips intellectual property rights. P&G said the court prohibited Onuge Personal Care (Guangzhou) from manufacturing, offering, selling, or distributing products that infringe P&G’s patents…